Halina Offner
Affiliations: | Neurology | Oregon Health and Science University, Portland, OR |
Area:
inflammation, brain injuryGoogle:
"Halina Offner"Mean distance: 53433
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kohs TCL, Fallon ME, Oseas EC, et al. (2023) Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice. Metabolic Brain Disease |
Wiedrick J, Meza-Romero R, Gerstner G, et al. (2020) Sex differences in EAE reveal common and distinct cellular and molecular components. Cellular Immunology. 104242 |
Brown J, Kingsbury C, Lee JY, et al. (2020) Spleen participation in partial MHC class II construct neuroprotection in stroke. Cns Neuroscience & Therapeutics |
Lee JY, Castelli V, Bonsack B, et al. (2019) A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental Stroke. Translational Stroke Research |
Seifert HA, Gerstner G, Kent G, et al. (2019) Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE. Journal of Neuroinflammation. 16: 195 |
Seifert HA, Zhu W, Vandenbark AA, et al. (2019) Sex differences in the therapeutic effects of anti-PDL2 neutralizing antibody on stroke. Metabolic Brain Disease |
Vandenbark AA, Meza-Romero R, Benedek G, et al. (2019) A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury. Journal of Neuroinflammation. 16: 14 |
Meza-Romero R, Benedek G, Gerstner G, et al. (2018) Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular construct. Metabolic Brain Disease |
Seifert HA, Offner H. (2018) The splenic response to stroke: from rodents to stroke subjects. Journal of Neuroinflammation. 15: 195 |
Seifert HA, Benedek G, Nguyen H, et al. (2018) Antibiotics protect against EAE by increasing regulatory and anti-inflammatory cells. Metabolic Brain Disease |